Mirum Pharmaceuticals Inc (MIRM) volume exceeds 1.03 million: A new investment opportunity for investors

Mirum Pharmaceuticals Inc (NASDAQ: MIRM) kicked off on Tuesday, down -0.94% from the previous trading day, before settling in for the closing price of $25.45. Over the past 52 weeks, MIRM has traded in a range of $22.34-$35.56.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


During the last 5-year period, the sales growth of Healthcare Sector giant was 88.90%. While this was happening, its average annual earnings per share was recorded 74.09%. With a float of $36.61 million, this company’s outstanding shares have now reached $46.72 million.

Let’s determine the extent of company efficiency that accounts for 264 employees.

Mirum Pharmaceuticals Inc (MIRM) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Mirum Pharmaceuticals Inc is 21.46%, while institutional ownership is 91.35%. The most recent insider transaction that took place on Mar 27 ’24, was worth 49,600. In this transaction CHIEF FINANCIAL OFFICER of this company bought 2,000 shares at a rate of $24.80, taking the stock ownership to the 14,000 shares. Before that another transaction happened on Mar 25 ’24, when Company’s PRESIDENT AND COO sold 4,303 for $25.80, making the entire transaction worth $111,017. This insider now owns 29,013 shares in total.

Mirum Pharmaceuticals Inc (MIRM) Recent Fiscal highlights

In the latest quarterly report, which was put into the public domain on 12/30/2023, the organization reported -$0.66 earnings per share (EPS), lower than consensus estimate (set at -$0.24) by -$0.42. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 74.09% per share during the next fiscal year.

Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Trading Performance Indicators

Take a look at Mirum Pharmaceuticals Inc’s (MIRM) current performance indicators. Last quarter, stock had a quick ratio of 4.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.30.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.03, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach 0.62 in one year’s time.

Technical Analysis of Mirum Pharmaceuticals Inc (MIRM)

Looking closely at Mirum Pharmaceuticals Inc (NASDAQ: MIRM), its last 5-days average volume was 0.57 million, which is a drop from its year-to-date volume of 0.6 million. As of the previous 9 days, the stock’s Stochastic %D was 20.66%. Additionally, its Average True Range was 1.13.

During the past 100 days, Mirum Pharmaceuticals Inc’s (MIRM) raw stochastic average was set at 4.70%, which indicates a significant decrease from 9.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.37% in the past 14 days, which was lower than the 48.23% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $27.33, while its 200-day Moving Average is $28.28. However, in the short run, Mirum Pharmaceuticals Inc’s stock first resistance to watch stands at $25.40. Second resistance stands at $25.59. The third major resistance level sits at $25.88. If the price goes on to break the first support level at $24.92, it is likely to go to the next support level at $24.63. Now, if the price goes above the second support level, the third support stands at $24.44.

Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Key Stats

The company with the Market Capitalisation of 1.18 billion has total of 47,003K Shares Outstanding. Its annual sales at the moment are 186,370 K in contrast with the sum of -163,420 K annual income. Company’s last quarter sales were recorded 69,550 K and last quarter income was -35,660 K.